Denali Therapeutics Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2015 | — | $-15.6M | $30.8M |
| FY2016 | — | $-94.2M | $39.9M |
| FY2017 | — | $465.8M | $218.4M |
| FY2018 | — | $546.8M | $77.1M |
| FY2019 | — | $394.9M | $79.4M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2015 | — | $-15.6M | $30.8M |
| FY2016 | — | $-94.2M | $39.9M |
| FY2017 | — | $465.8M | $218.4M |
| FY2018 | — | $546.8M | $77.1M |
| FY2019 | — | $394.9M | $79.4M |